🇺🇸 FDA

Drug profile · INN

dapsone

DAPSONE

approved
US status
approved
Patents linked
2
News articles
0

Quick answer

dapsone (DAPSONE) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: topical. Current US regulatory status: approved.

Key facts

INN dapsone
Brand DAPSONE
Route TOPICAL
Formulation GEL
Originator Amneal Pharma Europe Ltd

Related patents

Search patents →

  1. US 11273132

    Topical dapsone and dapsone/adapalene compositions and methods for use thereof

    Expires Mon Mar 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11116733

    Topical dapsone and dapsone/adaplene compositions and methods for use thereof

    Expires Mon Sep 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is dapsone?

dapsone (DAPSONE) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: topical. Current US regulatory status: approved.

What is the brand name for dapsone?

DAPSONE is a marketed brand name for dapsone. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of dapsone?

dapsone has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.